2021
DOI: 10.1039/d1cs00559f
|View full text |Cite
|
Sign up to set email alerts
|

Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics

Abstract: This tutorial review highlights the potential of nanoscale porous organic polymers in diagnosis and therapy of different types of cancers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
109
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 143 publications
(109 citation statements)
references
References 50 publications
0
109
0
Order By: Relevance
“…[10][11][12][13][14][15][16] For nanomedicine development, it is inevitable to choose a suitable nanomaterial as a platform. Various nanomaterials including organic nanomaterials such as liposomes, micelles, dendrimers, polymers, etc., [17][18][19][20][21][22] and inorganic nanomaterials such as ultrasmall iron oxide (Fe 3 O 4 ), gold, silica (SiO 2 ), layered double hydroxide (LDH), laponite ® (LAP) nanoparticles (NPs), etc. 5,[23][24][25] have been extensively explored.…”
Section: Introductionmentioning
confidence: 99%
“…[10][11][12][13][14][15][16] For nanomedicine development, it is inevitable to choose a suitable nanomaterial as a platform. Various nanomaterials including organic nanomaterials such as liposomes, micelles, dendrimers, polymers, etc., [17][18][19][20][21][22] and inorganic nanomaterials such as ultrasmall iron oxide (Fe 3 O 4 ), gold, silica (SiO 2 ), layered double hydroxide (LDH), laponite ® (LAP) nanoparticles (NPs), etc. 5,[23][24][25] have been extensively explored.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, the counterions in cationic COFs could be replaced with negatively charged metabolic inhibitors and chemotherapeutic drugs via ion exchange. 39 Thus, multifunctional COF-based siRNA delivery and metabolic therapy could be logically achieved.…”
Section: Introductionmentioning
confidence: 99%
“…With the development of these advanced technologies, multimodal systems combining imaging and drug therapy have become the focus of interest due to their theranostic functions [ 13 , 14 ]. However, the design of theranostic probes generally involves the modification of nanomaterials or conjugation of fluorescent probes to bioactive drugs, which involves a complicated system, and it is hard to effectively control their cellular and in vivo behaviors [ 15 ].…”
Section: Introductionmentioning
confidence: 99%